2022
Proceedings of the National Academy of Sciences of the United States of America, (2022).119 37 10.1073/pnas.2203019119.
2022
Journal of Public Health in Africa, (2022).13 3 10.4081/jphia.2022.2222.
2022
Trials, (2022).23 1 10.1186/s13063-022-06672-4.
2022
Frontiers in pediatrics, (2022).10, 10.3389/fped.2022.930348.
2022
Journal of medical entomology, (2022).59 6 10.1093/jme/tjac120.
2022
Disability and Rehabilitation, (2022).45 19 10.1080/09638288.2022.2118870.
2022
Implementation Science, (2022).17 1 10.1186/s13012-022-01228-1.
2022
Reproductive health, (2022).19 1 10.1186/s12978-022-01485-9.
Memory B-cell responses to different HPV vaccine regimes: Results from a dose-reduction randomised open-label trial (DoRIS) among Tanzanian school girls up to thirty-six months post-vaccination.
2022
(2022).
Immunobridging single-dose HPV vaccine in Tanzanian girls (DoRIS trial) to Kenyan women in whom single-dose efficacy has been demonstrated (KEN SHE trials).
2022
(2022).
